An inhibitor of ABHD18
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ABD646

Item No. 44548

Technical Information
Formal Name
5-((4-(methylsulfonyl)benzyl)oxy)-3-(4-(trifluoromethyl)benzyl)-1,3,4-oxadiazol-2(3H)-one
Molecular Formula
C18H15F3N2O5S
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/ml
SMILES
O=C1OC(OCC2=CC=C(S(=O)(C)=O)C=C2)=NN1CC3=CC=C(C(F)(F)F)C=C3
InChi Code
InChI=1S/C18H15F3N2O5S/c1-29(25,26)15-8-4-13(5-9-15)11-27-16-22-23(17(24)28-16)10-12-2-6-14(7-3-12)18(19,20)21/h2-9H,10-11H2,1H3
InChi Key
OYDYQXBJLGIHAN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    ABD646 is an inhibitor of α/β-hydrolase domain-containing protein 18 (ABHD18).1 It reduces ABHD18 activity in a mass spectrometry activity-based protein profiling (MS-ABPP) analysis using a 1:1 mixture of THP-1:COLO 205 cell lysates at 1 and 10 µM. ABD646 reduces the ratio of monolysocardiolipin to cardiolipin (MLCL:CL) in HAP1 tafazzin-knockout cells when used at a concentration of 5 µM. It also reduces the MLCL:CL ratio, improves mitochondrial respiratory chain activity, and improves mitochondrial morphology in skin fibroblasts derived from patients with Barth syndrome, an X-linked disorder associated with mutations in TAFAZZIN. ABD646 (1 µM) improves heart morphology in tafazzin-deficient zebrafish embryos.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Masud, S.N., Srivastava, A., Mero, P., et alGenetic suppression features ABHD18 as a Barth syndrome therapeutic target. Nature 645(8082), 1029-1038 (2025).